Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation

Study Questions:

What is the relative cost-effectiveness of available anticoagulation therapies for nonvalvular atrial fibrillation?